Status:
COMPLETED
Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age
Lead Sponsor:
Forest Laboratories
Conditions:
Infection
Eligibility:
All Genders
12-17 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects
Detailed Description
The purpose of this study is to determine the pharmacokinetics profile of ceftaroline in pediatric subjects
Eligibility Criteria
Inclusion
- Hospitalized and receiving antibiotic therapy for treatment of a suspected infection of any type
- Body mass index (weight \[kg\]/height squared \[m2\]) of no more than 30
- Males and females between 12 and 17 years of age, inclusive
Exclusion
- History of any hypersensitivity or allergic reaction to any β-lactam antimicrobial
- Past or current history of epilepsy or seizure disorder
- Critically ill or unstable patients
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00633126
Start Date
March 1 2008
End Date
February 1 2009
Last Update
March 14 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigational Site
Louisville, Kentucky, United States, 40202
2
Investigational Site
Durham, North Carolina, United States, 27710
3
Investigational site
Akron, Ohio, United States, 44308
4
Invetigational Site
Cleveland, Ohio, United States, 44106